Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 1 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 3 |
Descriptor
Autism | 3 |
Behavior Modification | 3 |
Pervasive Developmental… | 3 |
Behavior Problems | 2 |
Check Lists | 2 |
Children | 2 |
Intervention | 2 |
Antisocial Behavior | 1 |
Attendance | 1 |
Behavior Disorders | 1 |
Comparative Analysis | 1 |
More ▼ |
Source
Journal of Autism and… | 3 |
Author
Publication Type
Journal Articles | 3 |
Reports - Research | 3 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 3 |
What Works Clearinghouse Rating
Scheithauer, Mindy; Call, Nathan A.; Lomas Mevers, Joanna; McCracken, Courtney E.; Scahill, Lawrence – Journal of Autism and Developmental Disorders, 2021
Elopement is a common and dangerous concern in autism spectrum disorder (ASD). There is evidence that behavior analytic treatments can successfully treat elopement, but the research is limited due to small samples and treatment components varying across studies. The current study evaluated the feasibility of studying a manualized intervention for…
Descriptors: Randomized Controlled Trials, Intervention, Behavior Problems, Children
Bearss, Karen; Johnson, Cynthia; Handen, Benjamin; Smith, Tristram; Scahill, Lawrence – Journal of Autism and Developmental Disorders, 2013
Guidance on effective interventions for disruptive behavior in young children with autism spectrum disorders (ASDs) is limited. We present feasibility and initial efficacy data on a structured parent training program for 16 children (ages 3-6) with ASD and disruptive behavior. The 6-month intervention included 11 Core and up to 2 Optional…
Descriptors: Parents, Autism, Young Children, Parent Education
Pandina, Gahan J.; Bossie, Cynthia A.; Youssef, Eriene; Zhu, Young; Dunbar, Fiona – Journal of Autism and Developmental Disorders, 2007
Subgroup analysis of children (5-12 years) with autism enrolled in an 8-week, double-blind, placebo-controlled trial of risperidone for pervasive developmental disorders. The primary efficacy measure was the Aberrant Behavior Checklist-Irritability (ABC-I) subscale. Data were available for 55 children given risperidone (n = 27) or placebo (n =…
Descriptors: Autism, Drug Therapy, Children, Behavior Modification